Related Experiment Video
Updated: Jul 10, 2026
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Elevated platelet beta-secretase activity in mild cognitive impairment
1Division of Psychiatry and Neuroscience, School of Medicine and Dentistry, Queen's University Belfast, Belfast, UK.
Platelet beta-secretase activity, an enzyme linked to Alzheimer's disease, is elevated in individuals with mild cognitive impairment (MCI). This finding suggests potential diagnostic markers for early dementia stages.
Area of Science:
- Neuroscience
- Biochemistry
- Gerontology
Background:
- Platelet activity of beta-secretase, key in amyloid peptide production, is elevated in Alzheimer's disease.
- Mild cognitive impairment (MCI) precedes dementia and indicates higher conversion risk.
- Studying MCI offers insight into early pathological mechanisms.
Purpose of the Study:
- To quantify platelet membrane beta-secretase activity in individuals with MCI.
- To compare enzyme activity between MCI patients and healthy controls.
Main Methods:
- Developed and utilized a fluorimetric assay.
- Assessed platelet membrane beta-secretase activity.
- Included 52 MCI patients and 75 controls.
Main Results:
- Platelet beta-secretase activity was 24% higher in MCI patients versus controls.
- The difference was statistically significant (p = 0.001).
Conclusions:
- Elevated platelet beta-secretase activity observed in MCI warrants further investigation.
- This finding may contribute to understanding MCI etiology and diagnosis.
More Related Videos
09:31Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
11:03Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets
Published on: February 10, 2020
